From New Mechanisms to New Standards of Care
Focusing on Improving Patient Outcomes in Infectious Diseases
Latest News
News / 14 Apr 2019
Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteriaceae in Oral Session at ECCMID 2019
News / 03 Apr 2019
Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae
News / 02 Apr 2019
Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference
We are building a very different antibiotics company that focuses on bringing innovation to antibiotic development. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Chief Executive Officer
For Investors
Visit our dedicated section for investors that contains the latest available financial and regulatory information
Latest Event
ECCMID 2019
Our Discuva Platform
Our technology platform is at the heart of our research to develop new mechanism antibiotics